Response to Comments: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test

This document (A56315) is an administrative response to comments regarding the MolDX Envisia (Veracyte) diagnostic test for idiopathic pulmonary fibrosis and only records comment/notice periods and the LCD effective date. It does not provide clinical coverage criteria, limitations, documentation requirements, or frequency limits for the test.

"Document provides administrative notice only (comment and notice periods and LCD effective date) and does not state clinical coverage, documentation, or billing requirements for the Envisia/Veracyt..."

Sign up to see full coverage criteria, indications, and limitations.